What increased bone fracture risk has been reported in women taking the pioglitazone component of Competact?

In pooled randomised, controlled, double-blind trials, women taking pioglitazone, a component of Competact, experienced 1.9 fractures per 100 patient-years versus 1.1 with comparators, an excess of 0.8 fractures per 100 patient-years.